USA-based Interleukin Genetics has launched its new Inherent Health brand of genetic tests and related programs including the first-of-its-kind test for weight management that identifies an individual's genetic tendencies for weight gain and metabolism.
The firm says the Inherent Health brand offers customers a full suite of affordable, easy-to-use and meaningful genetic tests in heart health, bone health and nutritional needs, as well as PST, the periodontal disease risk assessment test. The products permit focused, personalized guidance for individuals looking for insights on specific lifestyle changes that can be made based on their genetic results to impact their health and wellness.
Other products in the range include: the Heart Health Genetic Test, which identifies a person's genetic predisposition to heart attack based on inflammation; Nutritional Needs Genetic Test, which identifies DNA variations in genes crucial to B-vitamin metabolism and the ability to manage oxidative stress; and the Bone Health Genetic Test, which will be available during the second half of this year and will identify whether an individual is more likely to be susceptible to spine fractures and low bone mineral density-associated with osteoporosis.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze